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Abstract Determining the differential expression of
proteins under different conditions is of major importance
in proteomics. Since mass spectrometry-based proteomics
is often used to quantify proteins, several labelling strate-
gies have been developed. While these are generally more
precise than label-free quantitation approaches, they imply
specifically designed experiments which also require
knowledge about peptides that are expected to be measured
and need to be modified. We recently designed the 2DB
database which aids storage, analysis, and publication of
data from mass spectrometric experiments to identify
proteins. This database can aid identifying peptides which
can be used for quantitation. Here an extension to the
database application, named MSMAG, is presented which
allows for more detailed analysis of the distribution of
peptides and their associated proteins over the fractions of
an experiment. Furthermore, given several biological
samples in the database, label-free quantitation can be
performed. Thus, interesting proteins, which may warrant
further investigation, can be identified en passant while
performing high-throughput proteomics studies.
Keywords Quantitation  Quantification  Label-free 
Software  MS/MS  Spectral count
Introduction
Proteomics aims to elucidate the protein complement of a
genome taking into account the spatial and temporal
expression patterns of a protein. Post translational modifi-
cations (PTM) and differential expression levels are also
vitally important for understanding biological function
(Vissers et al. 2008). Relative quantitation of protein
expression levels under different physiological states can
aid in elucidating some of these areas and can further aid in
drug discovery and can lead to improved diagnostic
methods (Pan et al. 2008; Roddy et al. 2007). Mass spec-
trometry is the method of choice for investigating peptides
and their aggregates, proteins (Aebersold and Mann 2003).
Protein expression levels have a high dynamic range but
not all respond to regulatory events or disease with large
changes in abundance (Wang et al. 2008). Therefore,
quantifying protein content is of importance in compre-
hensive proteome analysis (Blagoev et al. 2004; Cravatt
et al. 2007). In quantitation, using MS and tandem-MS, two
general strategies need mentioning.
One of these involves differential labelling of peptides
in different samples. In this strategy, a label which changes
the mass such that the mass to charge ratio difference
between labelled and label-free peptides can be discerned
by a mass spectrometer (Gygi et al. 1999; Krijgsveld et al.
2003; Wang et al. 2008). The label can be incorporated
metabolically, after isolation of protein/peptide, or refer-
ence peptides can be spiked into the sample prior to mass
spectrometric analysis (Bantscheff et al. 2007).
Unfortunately, not all peptides ‘fly well’ and may thus
escape detection by mass spectrometric experiments
(Aebersold and Mann 2003). Furthermore, in high-thro-
ughput experiments many peptides are missed due to a
variety of reasons but they may be recovered by perform-
ing several mass spectrometric analyses of the same
sample (Elias et al. 2005). For this reason, quantitative
studies involving high-throughput experiments are com-
parably rare; more commonly, specific proteotypic peptides
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(Duncan et al. 2005) are selected, differentially labelled,
and measured by MS or MS/MS in separate experiments.
Labelling therefore implies an additional effort which
involves additional cost and time as well as a potential
increase in sample complexity (Yang et al. 2007) whereas
label-free quantitation may be done without additional
effort. Label-free quantitation may not be as precise;
results should thus be carefully interpreted. However, as a
bonus during high-throughput mass spectrometric experi-
ments, it can help to identify proteins whose differential
expression is worth closer evaluation.
Label-free quantitation determines the protein content
without the need of adding a marker to the peptide. This
idea is based on the notion that protein abundance and
number of spectra and intensity of precursor ions are
correlated (Higgs et al. 2005; Silva et al. 2005). One
method is based on counting the occurrence of precursor
peaks with the desired mass to charge (m/z) ratio taking
into account multiple charge states. Depending on the
mass accuracy, this can lead to significant problems when
analyzing complex mixtures because multiple peptides
will lead to ions with the same m/z ratio for one or
several of the m/z ratios for the peptide of interest. An
improvement over this method is to include the elution
time such that elution time and precursor mass form a
pair which is clearly more discriminative (Silva et al.
2005, 2006). Unfortunately, these data pairs need to be
established first which require additional MS analyses.
Later samples that are compared need to be normalized
with regard to differences in the elution profiles (America
and Cordewener 2008).
Another method, spectral counting (Gao et al. 2003;
Pang et al. 2002), is based on MS/MS analysis and the
correct assignment of peptides to the measured spectra
(Allmer et al. 2004; Bafna and Edwards 2001; Duncan
et al. 2005; Eng et al. 1994; Geer et al. 2004; Mann and
Wilm 1994; Perkins et al. 1999; Shevchenko et al. 1996;
Tabb et al. 2003). Based on the same idea as above, the
spectra that support a protein are counted and the sum is
compared across experiments. In this method, information
regarding peak abundance remains unused and the resolu-
tion as far as high-throughput experiments are concerned is
limited to high-abundant peptides and proteins since only
identified MS/MS spectra are used.
Another approach is viable which first quantifies the MS
and MS/MS data, and then identifies those spectra that
contribute most to the difference among samples (Hoe-
henwarter et al. 2008). Through their program ProtMAX,
these authors implemented this approach, which is depen-
dent on high-resolution mass spectra and employs a reverse
strategy as compared to the methods mentioned above.
Due to the large amount of data generated by high-
throughput mass spectrometric experiments manual data
processing is not feasible. Automated methods are there-
fore mandatory. Many software tools for this purpose have
been reviewed in Mueller et al. (2008). We recently
developed 2DB, a database to hold, study, and publish
proteomics data, as generated from MS experiments
(Allmer et al. 2008). An automated quantitation facility has
not been available in the 2DB software but is presented
herein. Since it seemed natural to incorporate this func-
tionality, two approaches to label-free quantitation have
been incorporated into the 2DB application and are pre-
sented. The aim of the newly developed tool, named
MSMAG, is the identification of peptides and proteins that
significantly change in abundance between several exper-
imental conditions. Utilization of multiple internal stan-
dards and a slightly changed spectral counting method are
new features that will be shown in detail. MSMAG further
enables the investigation of protein-expression profiles.
Materials and methods
A combination of spectral count and total ion current is
used to determine differential expression levels. The total
ion current (TIC) for all supporting peptides of a protein is
summed in each biological replicate after adjusting to
standard peptides, if given. The differential expression
levels are calculated by determining the ratio between the
normalized TIC sum of the reference sample and all other
samples. The samples used for quantitation were theoreti-
cally generated whereas the samples used to analyze pro-
tein expression were taken from a former study.
Dataset generation
It has been pointed out that the availability of benchmark
datasets is not sufficient in the field of peptide and protein
quantitation via a traditional single stage of MS (Schulz-
Trieglaff et al. 2008). This situation seems to be equally
severe when using MS2 data for quantitation; therefore no
suitable publicly available dataset could be found to be
used with MSMAG. The datasets described in Schulz-
Trieglaff et al. (2008) were used to generate a suitable
dataset mirroring a theoretical high-throughput experiment
using the big-three acquisition method, which automati-
cally measures an MS/MS spectrum for the three most
abundant precursor ions following a full scan. The datasets,
available at http://www.ebi.ac.uk/pride/ with the accession
numbers 8161–8168, are, to the best of my knowledge,
generated such that the proteins are present in equal
amounts. The underlying proteins and peptides were
retrieved from the author and are made available through
the 2DB database (see experiment descriptions at
http://www.biolnk.com/2db). Thereafter, the datasets were
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examined and for every fourth MS scan in the original
dataset three MS/MS spectra were generated using the
most abundant three peaks as precursor ions if their m/z
ratio coincided with one of the underlying peptides. In
cases where no peptide was able to explain the m/z of the
precursor ion up to a charge of five, no MS/MS spectrum
was generated. This could happen, for example, from the
incorporation of post-translational modifications in the
original datasets.
It was assumed that an MS/MS scan would approxi-
mately take the same amount of time as an MS scan. The
MS spectra were not represented in the resulting dataset
when generated in the ams format, suitable for import into
2DB, and thus the amount of generated MS/MS spectra is
25% less than the amount of MS spectra in the original
dataset. For each MS/MS spectrum, a, b, c, x, y, and z ions
were generated for m/z values between 200 and 2,000 with
their respective water and ammonium losses at an arbitrary
maximum charge five or less having been determined from
the precursor ion. The abundance of the precursor ion was
equally distributed over all generated fragment ions. Usu-
ally, less than the possible 1,800 MS/MS spectra were
generated from the original datasets comprised of 2,400
MS spectra due to the fact that some precursor peaks could
not be explained by the available peptides up to a charge of
five. An average of about 1,588 ± 38 MS/MS spectra was
generated from the eight datasets.
The resulting eight datasets thus contain data that can
substitute for high-throughput experiments with similar
inherent flaws such as many missing data points due to
scan speed restrictions, peptides masked due to their low
abundance and so forth. The MS/MS spectra are however
highly theoretical and do not closely model experimental
MS/MS spectra. Since the identification was done using a
small peptide set (588 distinct peptides) generated from
100 proteins, and the mapping could be achieved using the
peaks in the MS spectrum, the theoretical nature of the MS/
MS spectra is of low importance to the current study.
Another dataset was generated from the original data-
sets. This time a more targeted analysis, with a higher
degree of separation of the proteins applied to the MS/MS
experiment, was assumed. A similar experiment as above
was conducted with only two protein, IPI00108270.1 and
IPI00108277.5, out of the 100 proteins available in the
dataset.
The in silico tryptic digest of these proteins resulted in
significantly less distinct peptides, more than five amino
acids in length, than for the first experimental dataset. For
each full scan in the eight original MS datasets, the three
most abundant peaks corresponding to one of the peptides
in the set were selected and MS/MS spectra were generated
as described above. An average of about 144 ± 32 MS/MS
spectra was generated from the eight original datasets.
Although better, the results were not significantly dif-
ferent from the results using 100 proteins. Therefore,
another dataset was generated where out of the 200 most
abundant peaks in an MS spectrum for the first-three
matching peptides (see above) an MS/MS spectrum was
generated. It was assumed that the LC peak could be
approximated better using this method than the big-three
acquisition method as above. Unfortunately, a different
error was introduced in this case (Fig. 1).
While the number of supporting spectra increased as
compared to the big-three acquisition method, and the LC
peaks could be re-established better for the second of the
two methods described above the number of false positive
identification sharply increased.
All generated datasets are available for review at
http://www.biolnk.com/2db. All datasets are named using
their acquisition number. The three different data genera-
tion methods have been named 100p3o3, 2p3o3, and
2p3o200.
Implementation
The quantitation functionality was implemented in the
JAVATM (http://www.java.com/) programming language
in order to shift more of the computation from the server to
the client computer and thus allows more interactive data
analysis. MSMAG, developed in this study, depends on an
installation of the 2DB database application (Allmer et al.
2008), either locally or on a web server. The 2DB software
is available at no charge with source code openly available.
Data necessary for analysis are retrieved from the database
Fig. 1 Distribution of a representative peptide from the experiment
with the accession number 8161 using the big-three acquisition
method for theoretically generating a high-throughput MS/MS dataset
(ENEELK 3o3) and using the best 3 out of the first 200 precursor ions
(ENEELK 3o200). The area which most likely corresponds to the
elution time is highlighted
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in a three tier fashion. The request is sent to a PHP (http://
www.php.net) script which then queries the database and
returns the result set. The application is launched using
JAVATM Web Start and therefore no local installation of
the program is necessary. The Web Start feature also
insures that always the latest version of MSMAG is used
without the need of user intervention. Depending on the
experiments stored in the database, large amounts of data
may need to be transferred which calls for fast connec-
tions between clients and server. The tool presented here
is also available at no charge and is currently being
integrated into the 2DB package but its source is not yet
available since additional extensive work is expected (see
outlook).
2DB dependency
In addition to the dependencies mentioned in the ‘‘Imple-
mentation’’ section above, the software presented here is
directly dependent on 2DB, a database application for
storage, analysis, and presentation of data from MS
experiments. 2DB is open source and MSMAG depends
only on two scripts for data transfer, lending itself to facile
implementation in different software environments. While
2DB allows the storage of identifications without spectral
data, such data cannot be quantified with MSMAG and will
be ignored by the program. In future, the dependence of
MSMAG on actual fragmentation spectra may increase
when other types of quantitation methods are incorporated
into this software. Spectral counting, not depending on the
presence of a complete MS/MS spectrum, has recently
been enabled for 2DB. It is, however, limited to the com-
parison of two experiments at a time. Such a limitation
does not exist for MSMAG.
Data pooling
Sometimes several liquid chromatography (LC) fractions
or several bands/spots from gels need to be combined since
proteins of interest may smear over several bands/spots on
a gel or may be present in subsequent LC fractions. To
avoid manual computation in these cases, results can be
pooled based on their fraction using 2DB. In case more
fractions than those containing the protein are pooled, no
effect on the result is expected unless cleavage products of
the protein or non-proteotypic peptides are present in these
fractions. In most comparison modes, data pooling has to
be set specifically but for absolute protein quantification
over two or more experiments all peptides found anywhere
in the experimental context are pooled. Data pooling is
achieved using a tool provided with 2DB which requires
ownership of the experiments or administrative rights to
the instance of 2DB used for the analysis.
Working modes
Two modes of operation are currently supported in
MSMAG. On one hand, expression profiling can be per-
formed in order to examine the expression level of peptides
and proteins in the fractions of an experiment. On the other
hand, label-free differential protein expression can be
investigated among several experiments in the database.
Figure 2 displays the general flowchart for importing MS/
MS data to 2DB and the major steps used in MSMAG to
achieve expression profiling and quantitation.
The general flowchart in Fig. 2 indicates that data are
stored in 2DB and fed forward to MSMAG. In 2DB, when
data have been sufficiently reviewed it can be published,
for 2DB which means that the access constraints to the data
Fig. 2 Flowchart for achieving
an expression profile and
quantitation results with
MSMAG. On the right, the
processing steps in 2DB are
indicated. MSMAG can be used
following the import step; all
other steps are optional but do
not interfere with the usage of
MSMAG. In general, data are
fed from 2DB to MSMAG
which is indicated by the lock
and key shape of the two
sections. At left, the major steps
in MSMAG are shown
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can be adjusted such that it can be visible for a target group
(e.g., the public). The effect on MSMAG is the same as for
all other data in 2DB which means that the analysis and
results can be reproduced by anyone given the proper
access rights.
In the following, expression profiling and quantitation
will be described in more detail. Figure 2 may serve as a
guide in this context.
Expression profiling
The simplest analysis which can be done with MSMAG is
locating the percentage-wise distribution of identified
proteins over all the fractions in an experiment. This
includes all identifications of a protein not only the most
significant one. By analogy, for a one-dimensional gel
separation, a protein with high molecular mass will be
found at the top of the gel. If it is processed by endogenous
digestion, the proteolytic fragments will be found in later
bands. All instances and their distribution over the exper-
iment are visualised and such processing can thus be
uncovered. Each protein is usually identified by a set of
peptides whose composition may also vary between frac-
tions. The percentage distribution of peptides constituting a
protein is also shown for each peptide.
The motivation for performing such an analysis is at
least threefold. One is to investigate proteolytic control of
proteins under different experimental conditions. Further-
more, it aids in finding samples to pool for later differential
analysis of the overall protein content for different exper-
imental conditions. Finally, this analysis can help in
detecting proteotypic peptides for further investigations.
Label-free quantitation
Selecting two or more experiments, the problem is that
they need to be brought into correlation. This can be done
automatically if corresponding fractions have been named
consistently. If this is not the case, similar fractions can be
correlated by the pooling tool of 2DB described elsewhere
(e.g., see 2DB online help). Pooling is both valid within an
experiment, and among experiments but the semantics for
the label-free quantitation is slightly different. While
fractions pooled from different experiments will be quan-
tified, results within pooled fractions of one experiment
will actually be summed and subsequently quantified, i.e.,
compared to the other experiments. The last mode comes
into play if corresponding fractions between two experi-
ments are not named equally and pooling has not been
applied. In this case, all fractions of the experiments are
pooled and then the overall protein amount is quantified
among different experiments.
Often some proteins can serve as references for the
relative quantitation of other proteins. Housekeeping pro-
teins may be expected not to change under different
physiological conditions and can therefore be used as
standards. If some proteins can serve as such markers, their
peptides can be used to adjust the relative differential
protein expression among several biological samples. All
selected reference peptides are first quantified among the
selected experiments, if they occur in all of them, by the
third mode of quantitation (see above). The relative dif-
ference is then averaged over all selected references. This
averaged relative difference is then used to adjust the
results obtained from quantitation. Since each experiment
may incorporate errors at different stages of processing,
such standards can help in normalizing the data and thus
lead to more sound results. The remaining proteins in the
experiments are then quantified. If all samples do not
contain the protein in the same fraction, those samples
without the protein are set to zero to indicate this. All other
samples are relatively quantified with regard to the selected
sample. Thus by selecting different samples, the relative
quantitation is re-calculated to show the relative quantita-
tion with respect to the currently selected sample.
Calculations
For expression profiling, it is assumed that all measure-
ments are done subsequently and that a total ion current
(TIC), measured for a peptide at the beginning of an MS
run and at the end of an MS run, would stay constant if the
amount of peptide entering the mass spectrometer was the
same.
For expression profiling, the TICs of all supporting
spectra of a peptide are summed to yield an overall TIC.
The resulting peptide TICs are in the same fashion aggre-
gated to form a protein TIC. For each identification of a
protein or a peptide, in separate fractions, the percentage of
the TIC in that fraction from the overall TIC for that pro-
tein/peptide is calculated. The percentage from the overall
TIC is recorded for each protein/peptide and each fraction
of the experiment.
Calculations for label-free quantitation are done using
the total ion current for all peptide identifications. This
means that the relative quantitation is different from a
spectral count since spectra go into the calculation with
different weights according to their TIC. This also means
that providing reference peptides for the calculation is
essential with respect to the fact that between different
runs, even on the same mass spectrometer, the total ion
current can vary significantly. Therefore, adjusting the
results by a factor, intrinsic to each MS run, can help to
account for this error.
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Proteins are aggregated from all their supporting pep-
tides as measured in the selected samples. The TICs for
these peptides are normalized using reference peptides, if
such were defined, and then summed to determine an
overall TIC for the protein. No attempt is made to restrict
the peptide set to peptides present in all samples simulta-
neously. Pooling will increase the summed total ion current
if the pooled fractions contain further supporting peptides
for the proteins that are quantified. Given normalized TICs
for each of the proteins in each of the samples, their rela-
tive abundance can be determined by simply selecting the
protein in one sample as a reference and dividing the TICs
of the protein in the other samples unless the TIC is zero. In
that case, the TICs are not divided but reported as
calculated.
In both modes, total ion current is used which is similar
as calculating protein abundance by the area under the
chromatographic peak. This is, however, only possible for
studies specifically designed with quantitation in mind.
Otherwise, the number of spectra for a peptide or protein
will not be enough to establish a good quality elution
profile thus the area under the peak cannot be calculated
with high precision. The reasoning for incorporating the
TIC in the calculation is that the chance for measuring
spectra at their highest abundance in the LC profile is
greatest under normal acquisition settings such as big-
three. Thus, different samples will in general be compared
by spectra from the area of their highest abundance in the
corresponding LC profıle. Therefore, differences in LC
peak height can be captured using the TIC whereas dif-
ferences in overall abundance or LC peak width are rep-
resented by the number of spectra for a peptide/protein.
Example
A brief example, which may be reviewed at http://www.
biolnk.com/2db, containing data of an earlier study (Allmer
et al. 2006), shall clarify the importance of this extension
to 2DB for expression profiling. The theoretical dataset
generated in this study is intended to highlight the usage
of quantitation with MSMAG. Initially, a view of available
experiments within the database is displayed (Fig. 3).
This view of the accessible experiments in the database
currently allows for the decision to either perform an
expression profiling of one experiment or compare the
differential protein expression in several experiments.
Selecting several secondary nodes (here: 8161–8168),
brings up another dialog which will aid in analyzing dif-
ferential protein expression. Selecting one experiment (for
example T), displays the protein content per fraction for the
experiment which is useful for expression profiling.
The experiment names used here may appear cryptic but
more detailed descriptions are available in the online
database and in the respective publications.
Fig. 3 Initial view of MSMAG,
the quantitation and distribution
extension for 2DB. On the left
the available experiments are
displayed in a tree structure with
the all experiments generated in
this study marked. On the right
some quick help is displayed
which explains the next steps.
Clicking on Calculate in the
toolbar with the current
selection will for instance bring
up the quantitation results for
the eight selected experiments
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Expression profiling
As detailed earlier, it is important to know which fractions
actually contain an identifiable amount of a protein or
peptide for example to measure the associated sample with
different parameters. In order to, for example, enrich a
protein, its percent distribution over all fractions of an
experiment, may be of interest.
Lastly, the information may aid in identifying proteins
which may be proteolytically processed (Naumann et al.
2005). Figure 4 shows how MSMAG displays this
information.
A list of all proteins and identified peptides, not asso-
ciated with proteins in the database, is presented in a tree
structure on the left of the graphical user interface. If a
protein is selected (here the protein with the JGI transcript
ID 184490), its distribution over all fractions of the
experiment is displayed. Below that view, the distribution
of the first of the supporting peptides, ordered alphabeti-
cally, is presented unless a different peptide has been
chosen from the list of supporting peptides for the protein.
A similar percent distribution indicates that the peptide is
always supporting the protein identification. Expanding the
protein node displays all supporting peptides found in the
sample. Selecting one of the peptides displays its percent-
wise distribution over the fractions of the sample. This can
aid in identifying endogenous proteolytic processing. In
some of the fractions a larger amount of peptides supports
the occurrence of the protein but in subsequent,
chromatographically distant fractions, subsets of these
peptides identify the same protein possible cleavage of the
protein into two or more distinct fragments. From the
missing peptides it may also be speculated where,
approximately, the protein has been cleaved.
For a more detailed analysis of the results, it is often
important to know where on a gel or within which fractions
of an LC run a protein is located. This information can shed
light on post-translational modifications of a protein if
information about, for example, the isoelectric point has
been determined during the experiment.
Label-free quantitation
Selecting at least two experiments in the initial dialog
allows for the analysis of differential protein expression in
the selected experiments. The dialog shows the selected
experiments, all peptides shared among all the experi-
ments, and selected standards (Fig. 5).
If there are peptides shared across all experiments, they
can be dedicated as internal standards given that their
expression levels are not expected to vary under among
experimental conditions. These internal standards can
compensate for differences in processing and loading of
biological samples. Several peptides can be designated as
internal standards. Their average will be subsequently used
to normalize the protein expression ratios. On the right of
Fig. 5, the results of the quantitation for the experiments
8161–8168 are shown. These results can be copied and
Fig. 4 An example of a protein
distribution for the experiment
named T on
http://www.biolnk.com/2db.
The information for the protein
with the JGI transcript ID
184490 is expanded and the four
supporting peptides, with the
third one selected, are visible.
On the top right side the protein
distribution shows that this
protein was found in fractions 7
to 9 with the majority of the
protein found in fraction 8. The
selected peptide is almost
equally distributed over the
same range which can be seen in
the lower panel on the right
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pasted to any spread sheet application such as OpenOffice
Calc for further analysis.
It is impossible to automatically determine how frac-
tions from different experiments are to be combined.
Therefore, four different processing modes are available.
Fractions are quantitated, if they are from different
experiments and pooling has previously been defined for
them, using 2DB. Since this may amount to a large
manual workload, it is easier to give the same name to
corresponding fractions of different experiments. This is
the second mode which will look for fractions with the
same name in different experiments. Here pooling will be
applied internally if pooling has been set for several
fractions of one experiment. These results will be pooled
each time when any of the fractions are quantitated with
any fraction of another experiment. The third mode of
quantitation assumes that the fractions cannot be defined
well and therefore simply quantifies the complete protein/
peptide content of the experiment with the respective
protein/peptide content of the remaining experiments
regardless of the membership to a certain fraction. The
last mode, auto, in MSMAG first tries to find pooled
fractions to perform quantitation, if that fails it tries to
find fractions that are named equally. If that fails as well,
it looks for proteins which are shared among the experi-
ments and quantifies by whole protein/peptide content.
The results for the quantitation of experiments 8161–8168
without the selection of an internal standard are available
in Table 1.
An internal standard cannot be set due to the theoretical
nature of the data which did not take such standards into
account. However, in contrast to the expectation, the data
significantly benefited from normalization. Therefore, the
peptides FILTFNYGNHNYGLNR, GLCALLLLLELPPR,
LPFALATSSETVTFQTK, MAVILSLEQGNR, LQVLDQ
ELEHK, LMTLQHDLEMATMEAR, ISFLEGENNELQ
SR, and LMENNLIK were chosen as standards. A closer
analysis might have revealed a better suitable set of
peptides but the current selection already underlines the
usefulness of using standards.
From the 100 different proteins in the dataset, 83 were
identified and could be relatively quantified. This is sig-
nificantly more than that could be expected from an
experimental dataset where the number of proteins would
be higher and the number of identifications lower. In an
experimental dataset, the samples would therefore usually
be split into smaller fractions thus reducing the complexity
per fraction. This was not necessary in this dataset but
should greatly enhance the resolution and thus the result of
the experiment. However, the aim was to have a compa-
rable complexity to experimental studies and therefore no
further fractionation was performed.
The assumption for the original dataset is that all pro-
teins are represented in equal amounts in all experiments.
The model produced by Schulz-Trieglaff et al. is highly
accurate (Schulz-Trieglaff et al. 2008) but not perfect
which can account for a small fraction of the error that can
be deduced from Table 1. However, in the study, random
Fig. 5 The eight theoretical
datasets (8161–8168), which
can be found on
http://www.biolnk.com/2db, are
used for quantitation by name.
Since 8161 is selected, it serves
as the reference; all others are
shown with respect to their
relative difference to 8161. A
number of peptides have been
selected as internal standards
(bottom box on the left). On the
right the fractions that have
been pooled are spelled out in
the first column with all
experiments and the applicable
fractions as well as the protein
identifier are listed. The
following columns display the
differential protein expression
for the selected experiments
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Table 1 Results of the quantitation of a simulation of eight high-throughput experiments (accession numbers presented as column headers)
using big-three acquisition settings for 100 proteins
Protein accession/MS-dataset
accession
8161 8162 8163 8164 8165 8166 8167 8168 Average Deviation
117655.00 1.00 0.50 0.00 0.28 0.00 1.10 0.00 0.00 0.36 0.46
IPI00107908.1 1.00 0.78 2.39 1.98 0.88 3.81 0.29 2.39 1.69 1.16
IPI00107940.1 1.00 1.10 0.81 2.76 1.57 2.00 2.40 0.81 1.56 0.75
IPI00107941.1 1.00 0.20 0.18 0.00 0.43 0.46 0.20 0.18 0.33 0.31
IPI00107952.2 1.00 0.00 3.92 4.32 0.58 3.99 1.37 3.92 2.39 1.81
IPI00107954.3 1.00 270.28 0.00 442.44 31.64 367.82 68.25 0.00 147.68 183.34
IPI00107962.1 1.00 1.34 1.83 0.53 0.48 0.88 0.48 1.83 1.05 0.57
IPI00107965.1 1.00 0.00 0.00 0.00 0.00 1611.57 0.10 0.00 201.58 569.72
IPI00107975.9 1.00 0.24 0.89 0.69 0.42 1.02 0.40 0.89 0.69 0.30
IPI00107989.1 1.00 58.80 367.56 92.31 49.66 521.63 117.60 367.56 197.02 192.75
IPI00107992.1 1.00 1.15 0.06 0.31 0.78 1.89 0.27 0.06 0.69 0.64
IPI00108004.1 1.00 146.11 0.02 1494.89 1,946.53 479.16 570.71 0.02 579.81 747.47
IPI00108011.1 1.00 3.93 0.00 1.61 3.45 2.25 2.93 0.00 1.90 1.50
IPI00108041.1 1.00 0.49 2.91 2.39 0.46 2.77 0.74 2.91 1.71 1.13
IPI00108058.3 1.00 0.66 0.19 0.86 1.49 0.22 0.07 0.19 0.59 0.50
IPI00108061.3 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.35
IPI00108063.1 1.00 11.30 13.13 11.55 11.94 4.59 4.71 13.13 8.92 4.73
IPI00108066.2 1.00 0.51 2.77 2.03 2.14 4.10 1.54 2.77 2.11 1.13
IPI00108067.3 1.00 0.71 0.52 0.30 0.51 0.50 0.26 0.52 0.54 0.23
IPI00108079.1 1.00 10.44 2.77 7.35 5.11 4.91 1.82 2.77 4.52 3.15
IPI00108083.1 1.00 0.00 5.17 3.21 2.41 0.95 0.64 5.17 2.32 2.03
IPI00108098.1 1.00 3.11 0.42 3.18 0.00 1.67 0.64 0.42 1.31 1.24
IPI00108110.1 1.00 0.89 0.00 0.35 0.00 0.54 0.85 0.00 0.45 0.43
IPI00108111.1 1.00 2.60 2.08 1.83 3.37 10.13 7.86 2.08 3.87 3.29
IPI00108115.3 1.00 0.39 0.78 0.96 0.42 0.42 0.59 0.78 0.67 0.25
IPI00108122.1 1.00 4.20 23.59 17.89 2.96 37.22 24.55 23.59 16.88 12.93
IPI00108135.1 1.00 1.58 4.10 5.07 0.93 0.00 1.62 4.10 2.30 1.85
IPI00108140.1 1.00 0.63 0.28 1.46 0.84 0.00 0.00 0.28 0.56 0.52
IPI00108150.1 1.00 0.43 0.61 0.75 0.46 0.34 0.37 0.61 0.57 0.22
IPI00108151.1 1.00 0.55 5.67 4.10 0.43 7.11 0.66 5.67 3.15 2.78
IPI00108152.2 1.00 0.61 0.46 1.35 0.20 0.50 0.40 0.46 0.62 0.37
IPI00108170.1 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.35
IPI00108171.3 1.00 0.50 0.64 0.45 0.31 1.07 0.59 0.64 0.65 0.26
IPI00108174.2 1.00 0.51 0.00 0.04 0.19 0.49 0.23 0.00 0.31 0.35
IPI00108178.1 1.00 2.02 1.10 1.70 2.58 0.40 1.01 1.10 1.36 0.69
IPI00108184.1 1.00 1.49 2.35 0.89 1.54 3.69 0.85 2.35 1.77 0.98
IPI00108187.1 1.00 0.34 0.53 1.07 0.63 0.67 0.47 0.53 0.66 0.26
IPI00108189.4 1.00 0.33 0.17 1.17 0.43 1.44 0.00 0.17 0.59 0.54
IPI00108190.3 1.00 0.79 0.90 0.98 0.81 1.30 0.53 0.90 0.90 0.22
IPI00108200.2 1.00 3.50 1.16 2.58 0.33 4.24 0.49 1.16 1.81 1.45
IPI00108204.2 1.00 0.25 0.11 0.57 0.36 1.50 0.33 0.11 0.53 0.49
IPI00108206.1 1.00 1.44 2.03 1.77 1.46 1.98 1.55 2.03 1.66 0.36
IPI00108220.4 1.00 0.23 0.83 0.11 0.26 0.72 0.06 0.83 0.51 0.38
IPI00108260.1 1.00 0.68 0.84 2.87 1.20 1.31 0.83 0.84 1.20 0.71
IPI00108270.1 1.00 1.99 0.00 0.71 2.04 2.54 0.28 0.00 1.07 1.00
IPI00108277.5 1.00 0.68 0.25 1.36 0.42 0.23 1.22 0.25 0.68 0.46
IPI00108279.3 1.00 0.80 5.18 1.66 1.34 2.67 1.80 5.18 2.45 1.78
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noise was deliberately added to the ions such that their
abundance differs among the datasets. This can account for
some of the spread of the data. In this study, additional
inherent errors come into effect. Peptides measured in an
experiment may not be measured in another experiment.
Only 120 out of the 365 possible peptides were present in
all datasets which may mostly be due to masking of pep-
tides. This means that the peptide was never among
the most abundant three peaks of a full scan for that
experiment or it was, but at a time where MS/MS spectra
were measured instead of full scans. Proteins with a large
number of detectable peptides such as IPI00108270.1 have
a higher chance of being measured and are therefore gen-
erally closer to the expected relative difference.
Out of the 83 quantified proteins about 58% are within
an average relative difference between 0.5 and 2 for all
experiments where the expectation would have been 1. In
such a case it would be beneficial to pool the results of
Table 1 continued
Protein accession/MS-dataset
accession
8161 8162 8163 8164 8165 8166 8167 8168 Average Deviation
IPI00108287.1 1.00 0.00 1.59 0.47 1.39 2.39 2.50 1.59 1.37 0.87
IPI00108328.3 1.00 0.72 0.68 0.48 0.55 1.67 0.74 0.68 0.82 0.38
IPI00108337.5 1.00 0.57 0.45 0.54 0.38 0.74 0.15 0.45 0.54 0.25
IPI00108367.2 1.00 3.13 5.14 5.78 6.46 3.54 0.25 5.14 3.81 2.25
IPI00108376.1 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.35
IPI00108378.1 1.00 0.74 1.02 0.85 0.52 1.19 0.59 1.02 0.87 0.23
IPI00108389.5 1.00 0.37 1.47 0.78 0.67 1.01 0.62 1.47 0.92 0.40
IPI00108390.6 1.00 0.36 0.00 1.81 4.81 1.98 0.54 0.00 1.31 1.60
IPI00108418.1 1.00 2.80 7.54 2.34 7.54 5.87 7.00 7.54 5.20 2.72
IPI00108426.2 1.00 0.56 0.73 1.67 0.85 0.92 0.65 0.73 0.89 0.35
IPI00108427.5 1.00 1.57 5.42 4.21 3.22 13.70 3.96 5.42 4.81 3.94
IPI00108439.1 1.00 1.96 2.19 3.32 2.17 3.10 3.52 2.19 2.43 0.83
IPI00108444.1 1.00 0.50 0.08 1.26 0.28 0.30 0.60 0.08 0.51 0.43
IPI00108454.2 1.00 0.40 3.31 1.98 1.05 0.00 0.49 3.31 1.44 1.29
IPI00108457.1 1.00 3.71 1.35 4.80 1.64 7.68 1.23 1.35 2.85 2.39
IPI00108475.3 1.00 0.72 2.10 4.15 0.26 7.24 1.83 2.10 2.43 2.28
IPI00108478.1 1.00 0.96 1.41 2.41 0.76 1.73 0.79 1.41 1.31 0.56
IPI00108481.5 1.00 285.88 1,782.06 323.93 738.41 0.13 684.69 1,782.06 699.77 720.59
IPI00108482.1 1.00 0.79 1.01 0.00 0.92 0.50 0.54 1.01 0.72 0.36
IPI00108484.5 1.00 0.60 0.53 1.12 0.97 0.42 0.62 0.53 0.72 0.26
IPI00108492.1 1.00 0.69 0.29 0.00 1.49 1.99 1.08 0.29 0.85 0.67
IPI00108508.4 1.00 0.21 0.25 0.33 0.33 1.15 0.35 0.25 0.48 0.37
IPI00108549.2 1.00 0.33 0.00 0.24 0.33 0.75 0.25 0.00 0.36 0.35
IPI00108565.1 1.00 0.74 3.28 3.44 1.29 2.89 2.66 3.28 2.32 1.12
IPI00108569.1 1.00 0.55 1.65 1.99 1.23 1.93 1.07 1.65 1.38 0.50
IPI00108570.5 1.00 6.54 0.77 1.40 1.72 1.60 4.49 0.77 2.29 2.10
IPI00108579.3 1.00 1.47 4.30 0.70 1.94 0.00 1.28 4.30 1.87 1.60
IPI00108584.2 1.00 0.60 2.32 1.58 0.64 2.46 0.81 2.32 1.47 0.81
IPI00108596.1 1.00 0.00 0.00 1.33 2.51 3.65 0.00 0.00 1.06 1.38
IPI00108597.1 1.00 0.00 0.31 0.00 0.00 0.00 0.00 0.31 0.20 0.35
IPI00108606.1 1.00 0.19 0.00 0.00 0.35 0.00 0.66 0.00 0.28 0.38
IPI00108609.1 1.00 1.40 2.50 1.67 2.48 2.41 0.62 2.50 1.82 0.76
IPI00108610.1 1.00 0.00 2.89 5.74 0.00 0.00 3.26 2.89 1.97 2.08
IPI00108627.1 1.00 1.94 0.00 2.45 1.08 1.39 0.70 0.00 1.07 0.86
IPI00108657.1 1.00 0.22 1.31 0.98 1.09 1.80 0.00 1.31 0.96 0.59
IPI00108663.2 1.00 10.41 1.32 1.52 5.53 4.03 2.07 1.32 3.40 3.25
The identified proteins (accession numbers provided as row headers) are given with their relative quantity, normalized to the dataset with the
accession number 8161
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multiple biological replicates to maximize the number of
identified peptides and proteins per dataset, and thus
increase the resolution and accuracy of the results which
was not done for this dataset since no relationship among
the datasets was expected.
Note that this method guarantees that data actually
support the peptides which cannot be assured for quanti-
fication with full scans from high-throughput analyses
where each peak in the MS spectrum may be explained by
multiple possible peptides from the proteome of the
organism further complicated by multiple charge states and
possible post-translational modifications as well as differ-
ent types of noise.
In order to examine the effect of less complex samples,
the second experiment which involved just two proteins
was analyzed in the same fashion as the experiment
detailed above. Both proteins were present in equal
amounts in all experiments with the same limitations as
pointed out above. The resolution should increase since the
mixture is less complex (Table 2).
The deviation and the average of the measurements are
significantly better than the average presented in Table 1.
This is a little surprising since the re-established LC
profile did not meet the expectations. It was most likely
not re-established very precisely due to the generation
method which introduced a lot of false positive identifi-
cations for both generation methods. This can also be
seen in Fig. 1 where both re-established LC profiles have
multiple peaks which is unexpected. Using the big-three
acquisition method this was less pronounced, however,
the resolution suffered like the one seen at the left of the
highlighted area where the 3o200 method picks up more
peptides, completely re-establishing the first LC peak.
Results like these with a high number of false positives
(all identifications before scan number 700 and those
following scan number 800) are not to be expected with
an experimental dataset where MS/MS spectra are first
mapped to a proteome by software such as Mascot and
Sequest, and then filtered and imported into 2DB and
finally analyzed by MSMAG.
Discussion
Often label-free quantitation methods are targeted to a
highly specific environment and are not broadly applicable.
The quantitation software, Serac, by Old et al. (2005) for
instance directly depends on a commercial software pack-
age. Other studies directly use commercial software
packages for quantitation (Mintz et al. 2008). Census (Park
et al. 2008) is a software for quantitation, currently more
powerful than the one presented in this study, but with the
drawback of working directly from measured data and
therefore not as flexible in its application. ProteinQuant
(Mann et al. 2008) employs the same strategy. Further,
software tools employing the same idea as Serac are
reviewed in Mueller et al. (2008). We recently developed
2DB, a database to hold, study, and publish proteomics
data based on MS experiments (Allmer et al. 2008).
Therefore, the limitation, mentioned above, is not found in
MSMAG; the tool presented here can draw from the ability
of 2DB to abstract from instrumentation details and its
ability to combine results from multiple experiments as
well as its ability to integrate findings from multiple MS/
MS identification tools. 2DB can hold data generated from
high-throughput experiments allowing identification of
proteotypic peptides. These peptides identify only one
protein from the entirety of proteins of an organism which
is essential for precise quantitation. Furthermore, their
detectability via MS/MS has been confirmed due to their
presence in the database. Other approaches aim to predict
such peptides (Sanders et al. 2007), which underlines the
importance of knowledge about proteotypic peptides.
The automated quantitation facility, which so far was
not available in the 2DB software, has been presented
herein. Since it seemed natural to incorporate this func-
tionality, two approaches to label-free quantitation have
been incorporated into the 2DB application. The aim of
these tools is the identification of peptides and proteins that
significantly change in abundance between two conditions.
Their results cannot replace more targeted follow-up
experiments also including differential labelling strategies
Table 2 Results of the quantitation of a simulation of eight high-throughput experiments (presented with their accession numbers as column
headers) using big-three acquisition settings (3o3) as well as the best 3 out of the first 200 (3o200) for two different proteins
Protein accession/MS-dataset accession 8161 8162 8163 8164 8165 8166 8167 8168 Average Deviation
IPI00108270.1 (3o3) 1.00 0.37 0.84 0.88 0.50 1.02 0.53 0.84 0.75 0.25
IPI00108277.5 (3o3) 1.00 0.82 0.54 0.82 0.40 1.03 0.52 0.54 0.71 0.24
IPI00108270.1 (3o200) 1.00 0.61 1.16 1.10 0.92 1.42 0.89 1.16 1.03 0.24
IPI00108277.5 (3o200) 1.00 0.94 1.11 1.46 0.70 1.89 0.99 1.11 1.15 0.37
The accession numbers of the identified proteins are given with their relative quantity (presented as the row headers), normalized to the dataset
with the accession number 8161
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but they greatly simplify identification of potentially
interesting proteins and their proteotypic peptides as a
bonus in high-throughput studies.
It has been shown that the spectral counting in MS
driven proteomics has a higher linearity and the number of
quantifiable proteins is increased as compared to peak
integration (Wienkoop et al. 2006). Spectral counting,
however, makes no use of abundance information present
in either the precursor ion or the MS/MS spectrum. This is
why spectral counts are used in this study but are further
amended with total ion current data in order to exploit
abundance information. Another limitation to current
techniques is that they usually do not employ internal
standards as done explicitly in a study by Tabata et al.
(2007) and implicitly by Naumann et al. (2007). Internal
standards, if known, can be utilized in the tool developed in
this study. Tabata et al. (2007) used labelled standards in
their study. MSMAG aims to keep the complete process
label-free and does not employ labelling for the standards;
however, it enables the possibility of designating several
peptides as standards as proposed in other areas where
quantification is important for example during a real time
polymerase chain reaction experiment (Vandesompele
et al. 2002). MSMAG, presented here, enables investiga-
tion of protein expression profiles, and presents a new
method for label-free quantitation.
Conclusion
An extension to 2DB is presented which allows for thor-
ough investigation of protein and peptide occurrence
within an experiment to investigate endogenous proteolytic
processing and to pool fractions with similar protein con-
tent as well as to determine proteotypic peptides. The
software presented is furthermore suitable for label-free
quantitation for any number of experiments thus also
allowing analysis of time series which is important for the
investigation of protein expression dynamics (Mintz et al.
2008). The robustness of the results can be increased by
providing peptides that can serve as standards. A new
quantitation method is introduced which consists of spec-
tral counting amended with abundance information derived
from the total ion current of the supporting spectra.
Outlook
Currently, only label-free quantitation is possible with the
newly developed extension to 2DB. The database is, how-
ever, able to hold information about post-translational
modifications and is therefore well-equipped to repre-
sent modified or labelled peptides. In future, another mode
of operation will involve quantitation for any given
modification to a peptide, either a label or a PTM. The rel-
ative abundance of PTMs per protein and per fraction as well
as differential expression of PTM patterns is another analysis
that will be available in the near future which will aid in
biomarker discovery (Wei and Li 2009).
No statistical analysis of this method has been per-
formed since data were believed to be of low reproduc-
ibility and since no suitable benchmark dataset was
available. In light of evidence pointing towards good
reproducibility of label-free quantitation (Griffiths et al.
2001; Stevenson et al. 2008; Zhang et al. 2006), such
analyses are indicated and statistics will be presented along
with suitable benchmark quantitation data in the future.
Especially, the new label-free quantitation method, using
spectral counts and TIC, will be examined more closely
with regard to its statistical confidence in the future.
Acknowledgments I would like to thank Ritchie Eanes for proof-
reading and additional valuable comments on the paper. I am thankful
to Ole Schulz-Trieglaff for providing the underlying datasets from
their paper and additional clarifying information.
References
Aebersold R, Mann M (2003) Mass spectrometry-based proteomics.
Nature 422:198–207
Allmer J, Markert C, Stauber EJ et al (2004) A new approach that
allows identification of intron-split peptides from mass spectro-
metric data in genomic databases. FEBS Lett 562:202–206
Allmer J, Naumann B, Markert C et al (2006) Mass spectrometric
genomic data mining: novel insights into bioenergetic pathways
in Chlamydomonas reinhardtii. Proteomics 6:6207–6220
Allmer J, Kuhlgert S, Hippler M (2008) 2DB: a Proteomics database for
storage, analysis, presentation, and retrieval of information from
mass spectrometric experiments. BMC Bioinformatics 9:302
America AH, Cordewener JH (2008) Comparative LC–MS: a
landscape of peaks and valleys. Proteomics 8:731–749
Bafna V, Edwards N (2001) SCOPE: a probabilistic model for scoring
tandem mass spectra against a peptide database. Bioinformatics
17(Suppl 1):S13–S21
Bantscheff M, Schirle M, Sweetman G et al (2007) Quantitative mass
spectrometry in proteomics: a critical review. Anal Bioanal
Chem 389:1017–1031
Blagoev B, Ong SE, Kratchmarova I et al (2004) Temporal analysis
of phosphotyrosine-dependent signaling networks by quantita-
tive proteomics. Nat Biotechnol 22:1139–1145
Cravatt BF, Simon GM, Yates JR 3rd (2007) The biological impact of
mass-spectrometry-based proteomics. Nature 450:991–1000
Duncan DT, Craig R, Link AJ (2005) Parallel tandem: a program for
parallel processing of tandem mass spectra using PVM or MPI
and X!Tandem. J Proteome Res 4:1842–1847
Elias JE, Haas W, Faherty BK et al (2005) Comparative evaluation of
mass spectrometry platforms used in large-scale proteomics
investigations. Nat Methods 2:667–675
Eng J, Mccormack AL, Yates JRIII (1994) An approach to correlate
tandem mass spectral data of peptides with amino acid sequences
in a protein database. J Am Soc Mass Spectrom 5:976–989
Gao J, Opiteck GJ, Friedrichs MS et al (2003) Changes in the protein
expression of yeast as a function of carbon source. J Proteome
Res 2:643–649
1086 J. Allmer
123
Geer LY, Markey SP, Kowalak JA et al (2004) Open mass
spectrometry search algorithm. J Proteome Res 3:958–964
Griffiths WJ, Jonsson AP, Liu S et al (2001) Electrospray and tandem
mass spectrometry in biochemistry. Biochem J 355:545–561
Gygi SP, Rist B, a Gerber S et al (1999) Quantitative analysis of
complex protein mixtures using isotope-coded affinity tags. Nat
Biotechnol 17:994–999
Higgs RE, Knierman MD, Gelfanova V et al (2005) Comprehensive
label-free method for the relative quantification of proteins from
biological samples. J Proteome Res 4:1442–1450
Hoehenwarter W, van Dongen JT, Wienkoop S et al (2008) A rapid
approach for phenotype-screening and database independent
detection of cSNP/protein polymorphism using mass accuracy
precursor alignment. Proteomics 8:4214–4225
Krijgsveld J, Ketting RF, Mahmoudi T et al (2003) Metabolic
labeling of C. elegans and D. melanogaster for quantitative
proteomics. Nat Biotechnol 21:927–931
Mann M, Wilm M (1994) Error-tolerant identification of peptides in
sequence databases by peptide sequence tags. Anal Chem
66:4390–4399
Mann B, Madera M, Sheng Q et al (2008) ProteinQuant Suite: a
bundle of automated software tools for label-free quantitative
proteomics. Rapid Commun Mass Spectrom 22:3823–3834
Mintz M, Vanderver A, Brown KJ et al (2008) Time series proteome
profiling to study endoplasmic reticulum stress response.
J Proteome Res 7:2435–2444
Mueller LN, Brusniak MY, Mani DR et al (2008) An assessment of
software solutions for the analysis of mass spectrometry based
quantitative proteomics data. J Proteome Res 7:51–61
Naumann B, Stauber EJ, Busch A et al (2005) N-terminal processing
of Lhca3 is a key step in remodeling of the photosystem I-light-
harvesting complex under iron deficiency in Chlamydomonas
reinhardtii. J Biol Chem 280:20431–20441
Naumann B, Busch A, Allmer J et al (2007) Comparative quantitative
proteomics to investigate the remodeling of bioenergetic path-
ways under iron deficiency in Chlamydomonas reinhardtii.
Proteomics 7:3964–3979
Old WM, Meyer-Arendt K, Aveline-Wolf L et al (2005) Comparison
of label-free methods for quantifying human proteins by shotgun
proteomics. Mol Cell Proteomics 4:1487–1502
Pan J, Chen HQ, Sun YH et al (2008) Comparative proteomic analysis
of non-small-cell lung cancer and normal controls using serum
label-free quantitative shotgun technology. Lung 186:255–261
Pang JX, Ginanni N, Dongre AR et al (2002) Biomarker discovery in
urine by proteomics. J Proteome Res 1:161–169
Park SK, Venable JD, Xu T et al (2008) A quantitative analysis
software tool for mass spectrometry-based proteomics. Nat
Methods 5:319–322
Perkins DN, Pappin DJ, Creasy DM et al (1999) Probability-based
protein identification by searching sequence databases using
mass spectrometry data. Electrophoresis 20:3551–3567
Roddy TP, Horvath CR, Stout SJ et al (2007) Mass spectrometric
techniques for label-free high-throughput screening in drug
discovery. Anal Chem 79:8207–8213
Sanders WS, Bridges SM, Mccarthy FM et al (2007) Prediction of
peptides observable by mass spectrometry applied at the
experimental set level. BMC Bioinformatics 8(Suppl 7):23
Schulz-Trieglaff O, Pfeifer N, Gropl C et al (2008) LC-MSsim—a
simulation software for liquid chromatography mass spectrom-
etry data. BMC Bioinformatics 9:423
Shevchenko A, Jensen ON, Podtelejnikov AV et al (1996) Linking
genome and proteome by mass spectrometry: large-scale iden-
tification of yeast proteins from two dimensional gels. Proc Natl
Acad Sci USA 93:14440–14445
Silva JC, Denny R, Dorschel CA et al (2005) Quantitative proteomic
analysis by accurate mass retention time pairs. Anal Chem
77:2187–2200
Silva JC, Denny R, Dorschel C et al (2006) Simultaneous qualitative
and quantitative analysis of the Escherichia coli proteome:
a sweet tale. Mol Cell Proteomics 5:589–607
Stevenson SE, Chu Y, Ozias-Akins P et al (2008) Validation of gel-
free, label-free quantitative proteomics approaches: applications
for seed allergen profiling. J Proteomics 72(3):555–566
Tabata T, Sato T, Kuromitsu J et al (2007) Pseudo internal standard
approach for label-free quantitative proteomics. Anal Chem
79:8440–8445
Tabb DL, Saraf A, Yates JR 3rd (2003) GutenTag: high-throughput
sequence tagging via an empirically derived fragmentation
model. Anal Chem 75:6415–6421
Vandesompele J, De Preter K, Pattyn F et al (2002) Accurate
normalization of real-time quantitative RT-PCR data by geo-
metric averaging of multiple internal control genes. Genome
Biol 3:RESEARCH0034
Vissers JP, Pons S, Hulin A et al (2008) The use of proteome
similarity for the qualitative and quantitative profiling of
reperfused myocardium. J Chromatogr B Analyt Technol
Biomed Life Sci 877(13):1317–1326
Wang F, Ye M, Dong J et al (2008) Improvement of performance in
label-free quantitative proteome analysis with monolithic elec-
trospray ionization emitter. J Sep Sci 31:2589–2597
Wei X, Li L (2009) Mass spectrometry-based proteomics and
peptidomics for biomarker discovery in neurodegenerative
diseases. Int J Clin Exp Pathol 2:132–148
Wienkoop S, Larrainzar E, Niemann M et al (2006) Stable isotope-
free quantitative shotgun proteomics combined with sample
pattern recognition for rapid diagnostics. J Sep Sci 29:2793–
2801
Yang F, Jaitly N, Jayachandran H et al (2007) Applying a targeted
label-free approach using LC–MS AMT tags to evaluate changes
in protein phosphorylation following phosphatase inhibition.
J Proteome Res 6:4489–4497
Zhang B, Verberkmoes NC, Langston MA et al (2006) Detecting
differential and correlated protein expression in label-free
shotgun proteomics. J Proteome Res 5:2909–2918
Label-free quantitation, an extension to 2DB 1087
123
